Scientists seeking better way to screen chemicals for cancer-causing effects

June 25, 2015 by Dan Krotz
Scientists seeking better way to screen chemicals for cancer-causing effects
A better way to screen chemicals that may cause cancer is under development. This image shows in two dimensions what Berkeley lab scientists are working to achieve in three dimensions: cultures containing diverse cell types (seen here using red and green fluorescently labeled antibodies) in ratios and orientations observed in normal tissues. Credit: Paul Yaswen, Berkeley Lab

The vast majority of the thousands of chemicals in our homes and workplaces have not been tested to determine if they cause cancer. That's because today's options are lacking. Rodent tests are too slow, and cell culture tests don't replicate how cells interact in the body, so their relevance to cancer is limited. Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have set out to change that.

They're developing a more lifelike cell culture that could help researchers better identify chemicals that increase breast cancer susceptibility. The scientists will grow the culture using adult stem obtained from , which has not been done before. Unlike today's , their test will show if a chemical causes a breakdown in cell-to-cell communication, which is a fundamental defect of cancer.

"There are many ways in which cells communicate, but these processes aren't represented in conventional cell cultures that are composed of the same type of cell," says Paul Yaswen, a staff scientist in Berkeley Lab's Life Sciences Division who leads the effort with researchers from the Silent Spring Institute, Stanford University, and the University of Florida.

"But our cell cultures will have many different cell types, just like normal tissue, which will enable us to detect cell-to-cell communication as it occurs in the body," says Yaswen.

In the first step of the project, which is just getting started, scientists will use discarded normal human breast tissue to obtain . They'll then create the conditions for these to differentiate into specialized cells. Between 50 and 100 of these varied cells will form a three-dimensional, gland-like structure called an organoid that mimics the structure and function of real breast tissue.

The idea is to expose an organoid to a chemical and then watch for telltale changes that indicate the chemical could be a carcinogen, such as cell signaling gone awry.

"This will help triage chemicals," says Yaswen. "The test will help researchers screen which chemicals are possibly cancer-causing and need further study, and which chemicals are unlikely to be threats."

Their stem-cell approach promises to be a big improvement over current tests that use "monocultures" of identical cells. When these cell cultures are exposed to a foreign substance such as plastic, they shut down their organ-specific functions and respond as if they're repairing a wound. In other words, they go silent, which isn't good if the test is intended to model carcinogenic-specific changes such as a disruption in cellular communication.

In contrast, the diverse cells in the Berkeley Lab-developed organoids will maintain their ability to produce proteins and communicate with other cells, even when the cells are exposed to a . And compared to a rodent test that can take up two years, the organoids can deliver results in two weeks.

After developing the organoids, the scientists will validate them by exposing the organoids to 18 chemicals, some of which are known to cause cancer and some of which are known to be safe. They'll also use the knowledge gained from their experiments to build mechanistic models of the interactions between hormones and DNA-damaging carcinogens in the breast.

Explore further: Patient cancer cells help to test treatments

Related Stories

Patient cancer cells help to test treatments

May 7, 2015

A study, published today in Cell, demonstrates the power of organoids to capture, in three dimensions, the multiple mutations that occur in tumours. Organoids, small clusters of cells that accurately mimic the behaviour of ...

The newest precision medicine tool: Prostate cancer organoids

September 4, 2014

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting ...

Recommended for you

Cancer hijacks natural cell process to survive

June 26, 2017

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.

Targeted drug shows promise in rare advanced kidney cancer

June 23, 2017

Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gkam
1 / 5 (1) Jun 25, 2015
We really need this. Notice how some chemicals we have been using are now considered to be carcinogenic? That's because of Industrial Biotest, the conservative organization which was supposed to test the products instead just passed them.

When we found out, the government refused to make them test them for sure. Reagan just said it was not necessary. How many folk will get nasty diseases because of conservatism?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.